Le Lézard
Classified in: Business
Subject: STR

IIROC Trade Resumption - ONC


TORONTO, May 24, 2017 /CNW/ - Trading resumes in:

Company: Oncolytics Biotech Inc.

TSX Symbol: ONC (all issues)

Resumption (ET): 11:15 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 11:11
According to the latest Workforce Monitor® survey commissioned by the American Staffing Association and conducted online by The Harris Poll, 68% of Americans prefer a hybrid or in-person work schedule....

at 11:08
Nooks, the fastest-growing AI dialing & prospecting platform, announced today that it has raised $22M in Series A funding. The round was led by Lachy Groom with participation from Tola Capital and Stifel Venture Banking, bringing Nooks...

at 11:06
Didriks, your one-stop shop for all things home, is thrilled to announce the grand opening of a brand new outdoor furniture and parasol showroom conveniently located next to their store headquarters in Belmont Center. This dedicated space allows...

at 11:05
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended March 31, 2024, as approved by its Board of Directors. "We...

at 11:04
Pickleball can certainly lay claim as the fastest growing sport in America for the third year in a row with an estimated 36.5 million people playing the game at least once this past year according to the Sports & Fitness Industry Association (SFIA)....

at 11:03
Marpai, Inc. ("Marpai" or the "Company") , an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced...



News published on and distributed by: